:
Interest in indolic structure metabolites including a number of products of microbial biotransformation of the
aromatic amino acid tryptophan is increasingly growing. The review prepared by a team of authors is based on a close
scrutiny of data available in PubMed, Scopus, Cyberleninka, Clinical Trials, Cochrane Library, eventually narrowing the
search to a set of keywords as tryptophan metabolites; plasma metabolomics profiling; metabolomics fingerprinting; gas-,
liquid chromatography mass spectrometry; serotonin; melatonin; tryptamine; indoxyl sulfate; indole-3-acetic acid;
indole-3-propionic acid; 5-hydroxyindoleacetic acid; gut microbiota; microbial metabolites. It resulted in a summary that
outlines the pattern of changes in the level of indolic structure metabolites in a number of diseases and deals with the data
from the field of human microbiota metabolites. In modern experimental studies, including the use of gnotobiological
(germ-free) animals, it has been convincingly proved that the formation of tryptophan metabolites such as indole-3-acetic
acid, indole-3-propionic acid, tryptamine, and indoxyl sulfate is associated with gut bacteria. Attention to some
concentration changes of indolic compounds is due to the fact that pronounced deviations or a significant decrease of
these metabolites in the blood were found in a number of problematic cardiovascular, brain or gastrointestinal diseases.
The literature-based analysis allowed the authors to conclude that a constant (normal) level of the main metabolites of the
indolic structure in the human body is maintained by a limited list of strict anaerobic bacteria from the gut of a healthy
body belonging to the species of Clostridium, Bacteroides, Peptostreptococcus, Eubacteria, etc. The authors focus on
several metabolites of the indolic structure that can be called clinically significant in certain diseases, such as
schizophrenia, depression, atherosclerosis, colorectal cancer, etc. Determining the level of indole metabolites in the blood
can be used to diagnose and monitor the effectiveness of a comprehensive treatment approach.